Markets

Insider Trading

Hedge Funds

Retirement

Opinion

BigBear.ai Holdings Inc. (BBAI): Among the Best AI Penny Stocks to Buy According to Analysts

We recently compiled a list of the 10 Best AI Penny Stocks to Buy According to Analysts. In this article, we are going to take a look at where BigBear.ai Holdings Inc. (NYSE:BBAI) stands against the other AI penny stocks.

Kim Forrest, chief investment officer at Bokeh Capital Partners, recently appeared on CNBC’s ‘The Exchange’ on November 13 to discuss why tech could be a winner in a new Trump administration, focusing her discussion on the current state of AI, particularly the distinction between large language models and smaller, targeted AI solutions.

Forrest noted that while LLMs have garnered significant attention and represent impressive technological advancements, they are not without their flaws. Specifically, she pointed out that these models are still prone to errors, which can hinder productivity and limit their practical applications in real-world scenarios. This concern leads her to advocate for what she refers to as small AI, which emphasizes targeted solutions aimed at addressing specific problems rather than attempting to cover a broad spectrum of tasks.

Her background as a software engineer and her experience working with AI tools have shaped her perspective on the matter. She believes that smaller, more focused AI models will ultimately prove to be more effective in driving productivity gains. Unlike the more complex and exotic LLMs that may resemble something out of science fiction, like HAL 9000 from “2001: A Space Odyssey”, small AI solutions are designed to tackle particular challenges efficiently. Forrest argues that this targeted approach is where true productivity can be realized, making small AI a compelling area for future development and investment.

When discussing investment opportunities in the tech sector, she highlighted several key players in the semiconductor industry that are essential for powering AI technologies. NVIDIA was noted as a natural leader in this space due to its dominance in graphics processing units (GPUs) that are crucial for AI computations. However, she also expressed continued confidence in AMD, despite its recent struggles in the market.

In addition to semiconductor companies, Forrest pointed out opportunities within software firms that are leveraging AI technologies. Microsoft was cited as a prime example, the company is actively working on providing access to LLMs while also narrowing focus to practical applications. For instance, it’s developing finance-oriented GenAI tools designed specifically for accounting tasks. This kind of targeted application exemplifies how LLMs can be adapted for specific industries, enhancing their utility and effectiveness.

Forrest also mentioned C3.ai as another noteworthy player in the AI space. It offers targeted AI solutions but has a significant service component mixed into its revenue model. While this diversification can provide stability, she cautioned that it may also limit scalability compared to bigger companies, which primarily focus on software products with higher margins. She emphasized the importance of understanding the business models of these companies when considering investment opportunities.

Overall, her insights reflect a nuanced understanding of the current tech landscape and the potential of both small and large AI solutions. She advocates for a balanced investment strategy that recognizes the strengths and weaknesses of various companies within the AI ecosystem. As AI continues to evolve, Forrest’s perspective underscores the critical need for investors to remain adaptable and informed about emerging trends and innovations in this dynamic field, which is why we’re here with a list of the 10 best AI penny stocks to buy according to analysts.

Methodology

We used ETFs, stock screeners, and financial media reports to compile an initial list of the top AI penny stocks, with a share price under $5. From that list, we narrowed our choices to 10 AI penny stocks that analysts were the most bullish on. The stocks are ranked in ascending order of analysts’ upside potential.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

A closeup of a computer server rack surrounded by a CAT5 network of cables.

BigBear.ai Holdings Inc. (NYSE:BBAI)

Average Upside Potential: 89.87%

Share Price as of November 5: $1.61

Number of Hedge Fund Holders: 9

BigBear.ai Holdings Inc. (NYSE:BBAI) specializes in providing AI-powered decision intelligence solutions for sectors like national security, supply chain management, and digital identity. It utilizes advanced technologies such as machine learning and predictive analytics to help organizations make informed decisions in complex environments. Its services cater to clients in defense, transportation security, and logistics, among others. Solutions include data processing and visualization tools that enhance operational efficiency and support critical decision-making processes across industries.

The company reported its third-quarter 2024 financial results. Its revenue grew 22.12% to $41.51 million, driven by increased demand for its solutions. A key quarter highlight was securing a substantial 5-year production contract worth $165 million with the US Army to deliver the GFIM-OE. This project leverages AI to transform legacy systems into a modern, intelligent platform, enhancing data-centric force management.

BigBear.ai Holdings Inc. (NYSE:BBAI) remains optimistic about its long-term prospects, acknowledging the cautious approach of governments towards AI but emphasizing its team’s expertise and the value of its technology. The demonstration of ConductorOS, its AI orchestration platform, showcases its potential to revolutionize military operations.

In the civilian sector, its biometric verification solution, veriScan, is now operational at Denver International Airport. This deployment streamlines the boarding process for international passengers, highlighting the practical application of AI in everyday life.

Beyond these specific achievements, the company’s broader involvement in projects with the US Army and FAA demonstrates its ability to deliver complex AI solutions for government agencies. This positions it as a key player in the development and implementation of cutting-edge AI technologies.

Overall BBAI ranks 7th on our list of the best AI penny stocks to buy according to analysts. As we acknowledge the growth potential of BBAI as an investment, our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than BBAI but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article is originally published at Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…